238
Views
4
CrossRef citations to date
0
Altmetric
Research Articles

Identification of abelson tyrosine kinase inhibitors as potential therapeutics for Alzheimer’s disease using multiple e-pharmacophore modeling and molecular dynamics

&
Pages 883-896 | Received 21 Nov 2015, Accepted 11 Mar 2016, Published online: 07 Apr 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Faizul Azam, Nada Hussin Alabdullah, Hadeel Mohammed Ehmedat, Abdullah Ramadan Abulifa, Ismail Taban & Sreedevi Upadhyayula. (2018) NSAIDs as potential treatment option for preventing amyloid β toxicity in Alzheimer’s disease: an investigation by docking, molecular dynamics, and DFT studies. Journal of Biomolecular Structure and Dynamics 36:8, pages 2099-2117.
Read now
Chandrasekaran Ramakrishnan, Anthony Mary Thangakani, Devadasan Velmurugan, Dhanabalan Anantha Krishnan, Masakazu Sekijima, Yutaka Akiyama & M. Michael Gromiha. (2018) Identification of type I and type II inhibitors of c-Yes kinase using in silico and experimental techniques. Journal of Biomolecular Structure and Dynamics 36:6, pages 1566-1576.
Read now

Articles from other publishers (2)

Qiwen Peng, Min Zhang & Guoyue Shi. (2022) High-Performance Extended-Gate Field-Effect Transistor for Kinase Sensing in Aβ Accumulation of Alzheimer’s Disease. Analytical Chemistry 94:2, pages 1491-1497.
Crossref
Nivya James, V. Shanthi & K. Ramanathan. (2019) Density Functional Theory and Molecular Simulation Studies for Prioritizing Anaplastic Lymphoma Kinase Inhibitors. Applied Biochemistry and Biotechnology 190:4, pages 1127-1146.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.